Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematopoetic Stem Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 19 of 0 results

Not applicableStudy completedNCT01766934
What this trial is testing

Non-interventional, Long-term Safety Data Collection of Zarzio® / Filgrastim HEXAL® in Stem Cell Donors

Who this might be right for
Hematopoietic Stem Cell Mobilization
Sandoz 245
Early research (Phase 1)Study completedNCT01926899
What this trial is testing

Phase I Study Evaluating the Addition of Bortezomib to an Established Acute Graft Versus Host Disease Prophylaxis Regimen in Pediatric Allogeneic Hematopoietic Stem Cell Transplant Patients

Who this might be right for
Hematopoetic Stem Cell Transplant
Indiana University 15
Not applicableLooking for participantsNCT07107165
What this trial is testing

Psychosocial and Behavioral Intervention for Stem Cell Transplant Patients and Their Family Caregivers

Who this might be right for
Stem Cell TransplantHematopoetic Stem Cell TransplantHematopoetic Stem Cell Transplantation
University of Pittsburgh 208
Large-scale testing (Phase 3)Not Yet RecruitingNCT07686965
What this trial is testing

Lisaftoclax Plus Azacitidine Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia Patients at High Risk of Relapse

Who this might be right for
Acute Myeloid Leukemia (AML)Maintenance TreatmentHematopoetic Stem Cell Transplantation
Institute of Hematology & Blood Diseases Hospital, China 191
Testing effectiveness (Phase 2)Study completedNCT03993639
What this trial is testing

KRN125 for Mobilization of Hematopoietic Stem Cells

Who this might be right for
Peripheral Blood Stem Cell Transplantation
Kyowa Kirin Co., Ltd. 35
Post-approval studies (Phase 4)Study completedNCT04243681
What this trial is testing

Combination of Autologous MSC and HSC Infusion in Patients With Decompensated Cirrhosis

Who this might be right for
Cirrhosis, Liver
Asian Institute of Gastroenterology, India 5
Not applicableNot Yet RecruitingNCT07328724
What this trial is testing

Critical Illness After Hematopoietic Cell Transplantation

Who this might be right for
Critical IllnessVentilated PatientsHematopoetic Stem Cell Transplantation+1 more
Peking University People's Hospital 4,000
Early research (Phase 1)Study completedNCT02264873
What this trial is testing

Phase I, Dose Escalation Study of Decitabine

Who this might be right for
Leukemia, Lymphoblastic, AcuteLeukemia, Myeloid AcuteHematopoetic Myelodysplasia
University of Florida 3
Not applicableStudy completedNCT02225145
What this trial is testing

Fertility Preservation in Women Who Will Have Gonadotoxic Therapy or Hematopoetic Stem Cell Transplantation, and in Women With Sickle Cell Disease

Who this might be right for
HemoglobinStem Cell TransplantAplastic Anemia
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 22
Testing effectiveness (Phase 2)Looking for participantsNCT07252050
What this trial is testing

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseHematopoetic Stem Cell TransplantHaploidentical Hematopoietic Stem Cell Transplant+2 more
Arkansas Children's Hospital Research Institute 24
Early research (Phase 1)Study completedNCT00809250
What this trial is testing

Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome-Refractory Anemia With Excess Blasts
Dana-Farber Cancer Institute 33
Large-scale testing (Phase 3)Active Not RecruitingNCT05515029
What this trial is testing

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Calcineurin Inhibitor at Patients With Hemoblastosis

Who this might be right for
Acute Lymphoblastic LeukemiaMyeloblastic LeukemiaBiphenotypic Acute Leukemia+3 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 56
Not applicableStudy completedNCT07712835
What this trial is testing

ECMO Use in Pediatric Oncology and HSCT Patients: A Descriptive and Comparative Analysis

Who this might be right for
ECMO OutcomesRespiratory Failure (Pediatric Patients)Malignancies, Hematologic+2 more
Children's Mercy Hospital Kansas City 22
Not applicableNot Yet RecruitingNCT07145359
What this trial is testing

Virtual Reality Intervention for Symptom Management in Stem Cell Transplantation

Who this might be right for
Cancer and / or Hematological MalignancyHematopoetic Stem Cell TransplantationNursing Interventions+3 more
Halic University 30
Large-scale testing (Phase 3)Study completedNCT00001937
What this trial is testing

Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

Who this might be right for
AspergillosisCandidiasisFungemia+1 more
National Cancer Institute (NCI) 800
Testing effectiveness (Phase 2)Ended earlyNCT04971005
What this trial is testing

Ocrelizumab or Alemtuzumab Compared With Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis - a Phase-2 Randomised Controlled Trial

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Universitätsklinikum Hamburg-Eppendorf 1
Testing effectiveness (Phase 2)UnknownNCT01220544
What this trial is testing

Haploidentical Transplantation With Early Adoptive Transfer of CD56+CD3- NK Cells

Who this might be right for
Acute Myeloid LeukemiasAdvanced Hematological MalignanciesIndication for Allogeneic Stem Cell Transplantation+1 more
Charite University, Berlin, Germany 30
Large-scale testing (Phase 3)Active Not RecruitingNCT06475820
What this trial is testing

Preventing of GVHD With Post-transplantation Cyclophosphamide, Abatacept, Vedolizumab and Baricitinib at Children and Young Adults With Hemoblastosis

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaBiphenotypic Acute Leukemia+2 more
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 150
Testing effectiveness (Phase 2)Ended earlyNCT01757197
What this trial is testing

Phase II Study of Tocilizumab for Patients With Glucocorticoid-refractory Acute GVHD After Allogeneic Hematopoetic Stem Cell Transplant (HSCT)

Who this might be right for
Glucocorticosteroid Refractory Acute GVHD
Weill Medical College of Cornell University 2